Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Neos Therapeutics, Inc. logo — We are creating the Specialty Pharmaceutical Company of Tomo...

Neos Therapeutics, Inc.

We are creating the Specialty Pharmaceutical Company of Tomorrow...Today

Founded 2008 United States Grand Prairie, United States 31 employees Post Ipo Equity Total: $204.38M Biotechnology, Health and Wellness +1

General Information

Company Name Neos Therapeutics, Inc.
Founded Year 2008
Location United States Grand Prairie, United States +1
Employees 31
Industries Biotechnology, Health and Wellness, Life Sciences
Funding Stage Post Ipo Equity
Social

Get notified when Neos Therapeutics, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Neos Therapeutics, Inc.

Neos Therapeutics, Inc. is a pharmaceutical company founded in 2008, with a focus on developing, manufacturing, and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. The company's slogan "We are creating the Specialty Pharmaceutical Company of Tomorrow...Today" reflects its ambition to innovate within the pharmaceutical industry. Neos initially concentrates on treating ADHD and has two other branded product candidates that are XR medications in ODT or oral suspension dosage forms. The company received a significant $25.00M Post-IPO Equity investment on 01 February 2017, indicating investor confidence and potential for growth. This investment is a testament to the promise Neos holds in the pharmaceutical market and its potential for expansion and development. As the company continues to focus on its inventive drug delivery technologies and new product candidates, it will be interesting to see how it progresses and expands its presence in the biotechnology sector. Neos Therapeutics, Inc. is headquartered in the United States, positioning it within a leading hub for pharmaceutical innovation. With its innovative approach and impactful products in the pipeline, Neos has the potential to make a lasting mark within the biotechnology industry. For potential investors and venture capitalists, Neos Therapeutics, Inc. presents an intriguing opportunity to support and engage with a pioneering company in the pharmaceutical space.

Taxonomy: specialty pharmaceuticals, modified-release drug delivery, ADHD treatment, pharmaceutical manufacturing, proprietary drug delivery technology, XR medications, ODT dosage forms, oral suspension dosage forms

Funding Rounds & Investors (9)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• - 01 Feb 2017
Post-IPO Debt •••••• 1 •••• •••• 16 May 2016
Venture Round •••••• 4
Investor Investor Investor
•••• •••• 		19 Feb 2015
Debt Financing •••••• 1
Investor
23 Apr 2014
Series C •••••• - 23 Apr 2014

View All 9 Funding Rounds

Neos Therapeutics, Inc. Alternatives & Competitors

Neos Therapeutics, Inc. vs
BioNxt Solutions
BioNxt Solutions Canada

Transforming Patient Care with Next-Generation Drug Delivery Technologies

Post Ipo Equity
2 employees
Health Care, Pharmaceutical
Compare Neos Therapeutics, Inc. vs BioNxt Solutions
Neos Therapeutics, Inc. vs
ForTe-bv
ForTe-bv The Netherlands

Formulation technology solutions for the pharmaceutical & healthcare industries.

2 employees
Manufacturing
Compare Neos Therapeutics, Inc. vs ForTe-bv
Neos Therapeutics, Inc. vs
Delpharm
Delpharm France

A worldwide leader in contract development and manufacturing of medicines

Late Stage
3905 employees
Health Care, Manufacturing
Compare Neos Therapeutics, Inc. vs Delpharm

FAQ About Neos Therapeutics, Inc.

We are creating the Specialty Pharmaceutical Company of Tomorrow...Today
Neos Therapeutics, Inc. was founded in 2008.
Neos Therapeutics, Inc. is headquartered in Grand Prairie, United States.
Neos Therapeutics, Inc. operates in the following industries: Biotechnology, Health and Wellness, Life Sciences.
Neos Therapeutics, Inc. has approximately 31 employees.
Neos Therapeutics, Inc. has completed 9 funding rounds, raising a total of $204.38M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to Neos Therapeutics, Inc. include BioNxt Solutions, ForTe-bv, Delpharm, Beit Jala Pharmaceutical Company, LTS Lohmann Therapie-Systeme AG. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Neos Therapeutics, Inc. and BioNxt Solutions are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Neos Therapeutics, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes